More than a dozen health-care bankers changed firms in Q1, according to an Axios analysis.
Why it matters: Health care, minus biopharma, is one of few sectors that's relatively insulated from the deal-chilling impact of tariffs.
More than a dozen health-care bankers changed firms in Q1, according to an Axios analysis.
Why it matters: Health care, minus biopharma, is one of few sectors that's relatively insulated from the deal-chilling impact of tariffs.
